Volume 8, Issue 2 (2023)                   SJMR 2023, 8(2): 119-124 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nateghi M R, Saremi A, Abbasi B, Mokamelsefat L, Karimi-MansourAbad E. Understanding the Link Between Gestational Diabetes and Intrauterine Growth Restriction: A Comprehensive Narrative Review. SJMR 2023; 8 (2) : 6
URL: http://saremjrm.com/article-1-300-en.html
1- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran. & Sarem Cell Research Center (SCRC), Sarem Women’s Hospital, Tehran, Iran.
2- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran & Department of Medical Genetics, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran.
3- Sarem Gynecology, Obstetrics and Infertility Research Center, Sarem Women’s Hospital, Iran University of Medical Science (IUMS), Tehran, Iran.
Abstract:   (298 Views)
Gestational diabetes is a condition that affects a substantial number of expectant mothers, with profound implications for maternal and fetal health. Among its complications, intrauterine growth restriction (IUGR) has garnered significant scientific attention. IUGR, characterized by impaired fetal growth, presents both immediate and long-term health risks. The relationship between gestational diabetes and IUGR has been a subject of extensive investigation, with studies exploring its nature and strength. IUGR, arising from gestational diabetes, is a matter of growing concern due to its potential impacts on both mothers and infants. This narrative review aims to consolidate existing knowledge on this topic, discerning the connection between gestational diabetes and IUGR.
We provide a detailed comparison of IUGR and macrosomia (excessive fetal growth) in patients with gestational diabetes, highlighting the variations in prevalence, risk factors, management, and maternal and neonatal implications. While IUGR is less common (around 5%-10%), macrosomia occurs more frequently (20%-40% or higher) in gestational diabetes cases. The balance between preventing these conditions is a key challenge, requiring vigilant monitoring of blood glucose levels during pregnancy
Article number: 6
Full-Text [PDF 1379 kb]   (80 Downloads)    
Article Type: Analytical Review | Subject: Pregnancy Care
Received: 2023/07/2 | Accepted: 2023/09/6 | Published: 2024/03/16

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | {Sarem Journal of Medical Research}

Designed & Developed by : Yektaweb